RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VITALE C
Collezione AOU Alessandria

Items : 9

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. in British journal of haematology / Br J Haematol. 2025 Mar;206(3):924-929. doi: 10.1111/bjh.19976. Epub 2025 Jan 7.

2025
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Vitale C; Coscia M; Bruno B; Rambaldi A; Laurenti L; Krampera M; Gaidano G; Rivela P; Quaresmini G; Quaglia FM; Moia R; Innocenti I; Deodato M; Frustaci AM; Catania G; Boccellato E; Montalbano MC; Perutelli F;

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.

2023
AOU Alessandria
AOU Città della Salute di Torino

Montserrat E; Cuneo A; Rambaldi A; Coscia M; Iyengar S; Varettoni M; Vitale C; Vandenberghe E; Yassin M; Pocali B; Wróbel T; Segundo LYS; Wasik-Szczepanek E; van Gelder M; van Kampen R; Tonino SH; Van Der Spek E; Te Raa D; Shrestha A; Saghumyan G; Reda G; Mirás F; Milosevic I; Gutwein O; Karlsson LK; Del Poeta G; Capasso A; Tadmor T; Sportoletti P; et alii...

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino

Fazi P; Vignetti M; Guarini A; Cuneo A; Piciocchi A; De Propris MS; Nanni M; Del Giudice I; Neri A; De Novi LA; Albano F; Vitale C; Visentin A; Pietrasanta D; Mattiello V; Molinari MC; Liberati AM; Giordano A; Patrizi VB; Gottardi D; Galieni P; Deodato M; Arcari A; Musuraca G; Tani M; Levato L; Marchetti M; Massaia M; Rigolin GM; et alii...

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3875-3878. doi: 10.1182/bloodadvances.2022006964.

2022
AOU Alessandria
AOU Città della Salute di Torino

Trentin L; Angeletti I; Coscia M; Patti C; Sanna A; Murru R; Sapienza G; Cuccaro A; Marasca R; Sportoletti P; Morelli F; Chiarenza A; Vitale C; Moretti M; Tomasso A; Visentin A; Catania G; Piciocchi A; Autore F; Fresa A; Pietrasanta D; Innocenti I; Laurenti L;

Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. in Journal of hematology & oncology / J Hematol Oncol. 2022 Aug 26;15(1):116. doi: 10.1186/s13045-022-01333-0.

2022
AOU Alessandria

Antic D; Milic N; Chatzikonstantinou T; Scarfò L; Otasevic V; Rajovic N; Allsup D; Alonso Cabrero A; Andres M; Baile Gonzales M; Capasso A; Collado R; Cordoba R; Cuéllar-García C; Correa JG; De Paoli L; De Paolis MR; Del Poeta G; Dimou M; Doubek M; Efstathopoulou M; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Lopez-Garcia A; García-Marco JA; et alii...

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World Evidence. in Journal of clinical medicine / J Clin Med. 2022 Apr 7;11(8):2076. doi: 10.3390/jcm11082076.

2022
AOU Alessandria
AOU Città della Salute di Torino

Coscia M; Scarfò L; Visentin A; Vasile A; Rigolin GM; Vitale C; Marchetti M; Cuneo A;

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. in Blood / Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201.

2021
AOU Alessandria
AOU Città della Salute di Torino

Gaidano G; Tedeschi A; Scarfò L; Cuneo A; Trentin L; Reda G; Orsucci L; De Paoli L; Montalbano MC; Perutelli F; Boccellato E; Gentile M; Pennese E; Rivela P; Marchetti M; Murru R; Laurenti L; Rigolin GM; Cassin R; Vassallo F; Visentin A; Zamprogna G; Schiattone L; Porrazzo M; Griggio V; Salvetti C; Vitale C; Mauro FR; Foà R; et alii...

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. in Leukemia / Leukemia. 2021 Dec;35(12):3444-3454. doi: 10.1038/s41375-021-01450-8. Epub 2021 Nov 1.

2021
AOU Alessandria
AOU Città della Salute di Torino

Tadmor T; Stavroyianni N; Stanca O; Sportoletti P; Špa?ek M; Šimkovi? M; Shrestha A; Saghumyan G; Ruchlemer R; Rigolin GM; Reda G; Qvist K; Quaresmini G; Quaglia FM; Piskunova I; Popov VM; Pavlovsky MA; Papaioannou M; Orsucci L; Olivieri J; Rodrigues RN; Niemann CU; Munir T; Murru R; Morawska M; Motta M; Mirás F; Milosevic I; Mauro FR; et alii...

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. in Leukemia / Leukemia. 2020 Sep;34(9):2354-2363. doi: 10.1038/s41375-020-0959-x. Epub 2020 Jul 9.

2020
AOU Alessandria
AOU Città della Salute di Torino

Rossi D; Ortiz Pareja M; Papaioannou M; Hakobyan Y; Kalashnikova O; Enrico A; Doubek M; Dimou M; Andres M; Nikitin E; Dos Santos G; Chiarenza A; Barna G; Pocali B; Yassin M; Sportoletti P; Popov VM; Orsucci L; Malerba L; Kersting S; Kater AP; Jaksic O; Herold T; Herishanu Y; Foglietta M; Gentile M; Farina L; De Paolis MR; Del Poeta G; et alii...